Shares of Cencora, Inc. (NYSE:COR – Get Free Report) have been assigned an average rating of “Moderate Buy” from the fourteen ratings firms that are covering the firm, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and eleven have issued a buy recommendation on the company. The average 12-month target price among brokers that have issued a report on the stock in the last year is $367.75.
A number of equities analysts recently issued reports on the stock. Morgan Stanley set a $342.00 price target on shares of Cencora in a research note on Friday, May 8th. Bank of America lifted their target price on shares of Cencora from $280.00 to $285.00 and gave the stock a “neutral” rating in a report on Wednesday, June 24th. Weiss Ratings cut shares of Cencora from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, June 30th. Citigroup reduced their price target on shares of Cencora from $405.00 to $355.00 and set a “buy” rating for the company in a research report on Thursday, May 7th. Finally, Barclays lowered their price objective on Cencora from $425.00 to $350.00 and set an “overweight” rating on the stock in a research report on Wednesday, June 10th.
Get Our Latest Stock Analysis on COR
Insider Activity
Institutional Investors Weigh In On Cencora
Several hedge funds and other institutional investors have recently made changes to their positions in the business. Nordea Investment Management AB lifted its stake in shares of Cencora by 3.8% during the 4th quarter. Nordea Investment Management AB now owns 1,256,356 shares of the company’s stock valued at $426,715,000 after buying an additional 45,712 shares in the last quarter. Groupama Asset Managment bought a new stake in Cencora during the third quarter valued at about $1,225,000. Assetmark Inc. lifted its position in shares of Cencora by 57.0% in the fourth quarter. Assetmark Inc. now owns 67,281 shares of the company’s stock valued at $22,724,000 after acquiring an additional 24,431 shares in the last quarter. ExodusPoint Capital Management LP bought a new position in shares of Cencora in the fourth quarter worth about $16,487,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of Cencora by 162.4% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 289,370 shares of the company’s stock worth $97,735,000 after acquiring an additional 179,086 shares during the period. Hedge funds and other institutional investors own 97.52% of the company’s stock.
Cencora Trading Down 1.4%
Shares of NYSE COR opened at $303.65 on Friday. Cencora has a 1 year low of $244.82 and a 1 year high of $377.54. The stock has a market cap of $59.08 billion, a P/E ratio of 23.29, a price-to-earnings-growth ratio of 1.71 and a beta of 0.58. The firm has a 50-day moving average of $280.85 and a 200 day moving average of $317.26. The company has a debt-to-equity ratio of 3.40, a current ratio of 0.95 and a quick ratio of 0.59.
Cencora (NYSE:COR – Get Free Report) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $4.75 EPS for the quarter, missing analysts’ consensus estimates of $4.82 by ($0.07). Cencora had a return on equity of 135.20% and a net margin of 0.78%.The company had revenue of $78.36 billion during the quarter, compared to the consensus estimate of $81.09 billion. During the same period in the prior year, the firm earned $4.42 earnings per share. The business’s revenue for the quarter was up 3.9% compared to the same quarter last year. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. As a group, sell-side analysts expect that Cencora will post 17.79 EPS for the current fiscal year.
Cencora Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Monday, June 1st. Stockholders of record on Friday, May 15th were issued a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend was Friday, May 15th. Cencora’s payout ratio is presently 18.40%.
Cencora announced that its Board of Directors has authorized a share repurchase plan on Thursday, May 21st that authorizes the company to buyback $2.00 billion in shares. This buyback authorization authorizes the company to purchase up to 3.9% of its stock through open market purchases. Stock buyback plans are often an indication that the company’s management believes its shares are undervalued.
About Cencora
Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.
Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.
Featured Stories
- Five stocks we like better than Cencora
- The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence
- Is Domino’s Stock Serving Up a Buying Opportunity?
- A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free
- Why Gold Miners Could Be the Market’s Biggest Comeback Story
Receive News & Ratings for Cencora Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cencora and related companies with MarketBeat.com's FREE daily email newsletter.
